Literature DB >> 22043863

Increased brain-derived neurotrophic factor (BDNF) expression in the ventral tegmental area during cocaine abstinence is associated with increased histone acetylation at BDNF exon I-containing promoters.

Heath D Schmidt1, Gavin R Sangrey, Shayna B Darnell, Rachel L Schassburger, Jang-Ho J Cha, R Christopher Pierce, Ghazaleh Sadri-Vakili.   

Abstract

Recent evidence suggests that the persistence of cocaine seeking during periods of protracted drug abstinence following chronic cocaine exposure is mediated, in part, by neuroadaptations in the mesolimbic dopamine system. Specifically, incubation of cocaine-seeking behavior coincides with increased brain-derived neurotrophic factor (BDNF) protein expression in the ventral tegmental area (VTA). However, the molecular mechanisms that regulate time-dependent changes in VTA BDNF protein expression during cocaine abstinence are unclear. The goal of these experiments was to determine whether VTA BDNF transcript levels are altered following cocaine abstinence and identify the molecular mechanisms regulating cocaine-induced changes in VTA BDNF transcription. Rats were allowed to self-administer cocaine (0.25 mg/infusion, i.v.) for 14 days on a fixed-ratio schedule of reinforcement followed by 7 days of forced drug abstinence. BDNF protein and exon I-containing transcripts were significantly increased in the VTA of cocaine-experienced rats following 7 days of forced drug abstinence compared to yoked saline controls. Cocaine-induced changes in BDNF mRNA were associated with increased acetylation of histone 3 and binding of CREB-binding protein to exon I-containing promoters in the VTA. Taken together, these results suggest that drug abstinence following cocaine self-administration remodels chromatin in the VTA resulting in increased expression of BDNF, which may contribute to neuroadaptations underlying cocaine craving and relapse.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22043863      PMCID: PMC3243782          DOI: 10.1111/j.1471-4159.2011.07571.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  47 in total

Review 1.  Function and regulation of CREB family transcription factors in the nervous system.

Authors:  Bonnie E Lonze; David D Ginty
Journal:  Neuron       Date:  2002-08-15       Impact factor: 17.173

2.  Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2.

Authors:  Wen G Chen; Qiang Chang; Yingxi Lin; Alexander Meissner; Anne E West; Eric C Griffith; Rudolf Jaenisch; Michael E Greenberg
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

3.  DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation.

Authors:  Keri Martinowich; Daisuke Hattori; Hao Wu; Shaun Fouse; Fei He; Yan Hu; Guoping Fan; Yi E Sun
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

4.  Time-dependent increases in brain-derived neurotrophic factor protein levels within the mesolimbic dopamine system after withdrawal from cocaine: implications for incubation of cocaine craving.

Authors:  Jeffrey W Grimm; Lin Lu; Teruo Hayashi; Bruce T Hope; Tsung-Ping Su; Yavin Shaham
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

5.  A single infusion of brain-derived neurotrophic factor into the ventral tegmental area induces long-lasting potentiation of cocaine seeking after withdrawal.

Authors:  Lin Lu; Jack Dempsey; Shirley Y Liu; Jennifer M Bossert; Yavin Shaham
Journal:  J Neurosci       Date:  2004-02-18       Impact factor: 6.167

6.  Multiple promoters direct tissue-specific expression of the rat BDNF gene.

Authors:  T Timmusk; K Palm; M Metsis; T Reintam; V Paalme; M Saarma; H Persson
Journal:  Neuron       Date:  1993-03       Impact factor: 17.173

7.  Chromatin immunoprecipitation technique for study of transcriptional dysregulation in intact mouse brain.

Authors:  Melissa W Braveman; Alice S Chen-Plotkin; George J Yohrling; Jang-Ho J Cha
Journal:  Methods Mol Biol       Date:  2004

8.  Role of the dopamine D3 receptor in reactivity to cocaine-associated cues in mice.

Authors:  Bernard Le Foll; Henriette Francès; Jorge Diaz; Jean-Charles Schwartz; Pierre Sokoloff
Journal:  Eur J Neurosci       Date:  2002-06       Impact factor: 3.386

9.  The dopamine D1 receptor is a critical mediator for cocaine-induced gene expression.

Authors:  Dongsheng Zhang; Lu Zhang; Dan Wen Lou; Yusaku Nakabeppu; Jianhua Zhang; Ming Xu
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

Review 10.  p300/CBP proteins: HATs for transcriptional bridges and scaffolds.

Authors:  H M Chan; N B La Thangue
Journal:  J Cell Sci       Date:  2001-07       Impact factor: 5.285

View more
  44 in total

1.  Elevation of BDNF exon I-specific transcripts in the frontal cortex and midbrain of rat during spontaneous morphine withdrawal is accompanied by enhanced pCreb1 occupancy at the corresponding promoter.

Authors:  Danil I Peregud; Leonid F Panchenko; Natalia V Gulyaeva
Journal:  Neurochem Res       Date:  2014-11-13       Impact factor: 3.996

2.  Enhancement of BDNF Expression and Memory by HDAC Inhibition Requires BET Bromodomain Reader Proteins.

Authors:  Gregory C Sartor; Andrea M Malvezzi; Ashok Kumar; Nadja S Andrade; Hannah J Wiedner; Samantha J Vilca; Karolina J Janczura; Amir Bagheri; Hassan Al-Ali; Samuel K Powell; Peyton T Brown; Claude H Volmar; Thomas C Foster; Zane Zeier; Claes Wahlestedt
Journal:  J Neurosci       Date:  2018-11-30       Impact factor: 6.167

3.  Dose-dependent effects of wheel running on cocaine-seeking and prefrontal cortex Bdnf exon IV expression in rats.

Authors:  Alexis B Peterson; Jean M Abel; Wendy J Lynch
Journal:  Psychopharmacology (Berl)       Date:  2013-10-31       Impact factor: 4.530

Review 4.  The role of histone acetylation in cocaine-induced neural plasticity and behavior.

Authors:  George A Rogge; Marcelo A Wood
Journal:  Neuropsychopharmacology       Date:  2012-08-22       Impact factor: 7.853

Review 5.  Exercise as a novel treatment for drug addiction: a neurobiological and stage-dependent hypothesis.

Authors:  Wendy J Lynch; Alexis B Peterson; Victoria Sanchez; Jean Abel; Mark A Smith
Journal:  Neurosci Biobehav Rev       Date:  2013-06-24       Impact factor: 8.989

6.  Systemic Delivery of a Brain-Penetrant TrkB Antagonist Reduces Cocaine Self-Administration and Normalizes TrkB Signaling in the Nucleus Accumbens and Prefrontal Cortex.

Authors:  Michel M M Verheij; Leandro F Vendruscolo; Lucia Caffino; Giuseppe Giannotti; Maxime Cazorla; Fabio Fumagalli; Marco A Riva; Judith R Homberg; George F Koob; Candice Contet
Journal:  J Neurosci       Date:  2016-08-03       Impact factor: 6.167

7.  Neurotrophic factors in women with crack cocaine dependence during early abstinence: the role of early life stress.

Authors:  Thiago W Viola; Saulo G Tractenberg; Mateus Luz Levandowski; Júlio Carlos Pezzi; Moisés Evandro Bauer; Antonio Lúcio Teixeira; Rodrigo Grassi-Oliveira
Journal:  J Psychiatry Neurosci       Date:  2014-05       Impact factor: 6.186

8.  Resistance exercise decreases heroin self-administration and alters gene expression in the nucleus accumbens of heroin-exposed rats.

Authors:  Mark A Smith; Gaylen E Fronk; Jean M Abel; Ryan T Lacy; Sarah E Bills; Wendy J Lynch
Journal:  Psychopharmacology (Berl)       Date:  2018-02-02       Impact factor: 4.530

9.  Role of Dorsal Striatum Histone Deacetylase 5 in Incubation of Methamphetamine Craving.

Authors:  Xuan Li; Maria B Carreria; Kailyn R Witonsky; Tamara Zeric; Olivia M Lofaro; Jennifer M Bossert; Jianjun Zhang; Felicia Surjono; Christopher T Richie; Brandon K Harvey; Hyeon Son; Christopher W Cowan; Eric J Nestler; Yavin Shaham
Journal:  Biol Psychiatry       Date:  2017-12-29       Impact factor: 13.382

Review 10.  Regulation of chromatin states by drugs of abuse.

Authors:  Deena M Walker; Hannah M Cates; Elizabeth A Heller; Eric J Nestler
Journal:  Curr Opin Neurobiol       Date:  2014-12-06       Impact factor: 6.627

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.